tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Imugene Limited Announces Quotation of New Securities on ASX
Company AnnouncementsImugene Limited Announces Quotation of New Securities on ASX
5d ago
Imugene to Host Webinar on Azer-cel Phase 1b Trial Data
PremiumCompany Announcements
Imugene to Host Webinar on Azer-cel Phase 1b Trial Data
5d ago
Imugene Limited Announces Share and Options Offer to Raise $37.5 Million
PremiumCompany Announcements
Imugene Limited Announces Share and Options Offer to Raise $37.5 Million
5d ago
Imugene Limited Announces Capital Raising for Cancer Treatment Innovations
PremiumCompany Announcements
Imugene Limited Announces Capital Raising for Cancer Treatment Innovations
5d ago
Imugene Limited Announces Proposed Securities Issue to Support Cancer Immunotherapy Research
PremiumCompany Announcements
Imugene Limited Announces Proposed Securities Issue to Support Cancer Immunotherapy Research
5d ago
Imugene Limited Announces Proposed Securities Issue to Bolster Cancer Immunotherapy Efforts
PremiumCompany AnnouncementsImugene Limited Announces Proposed Securities Issue to Bolster Cancer Immunotherapy Efforts
5d ago
Imugene Secures $22.5M in Funding, Launches $15M Share Purchase Plan
Premium
Company Announcements
Imugene Secures $22.5M in Funding, Launches $15M Share Purchase Plan
5d ago
Imugene Limited Initiates Trading Halt for Capital Raising Announcement
Premium
Company Announcements
Imugene Limited Initiates Trading Halt for Capital Raising Announcement
7d ago
Imugene Reports Positive Results in Phase 1b CAR T Trial for DLBCL
PremiumCompany Announcements
Imugene Reports Positive Results in Phase 1b CAR T Trial for DLBCL
7d ago
Imugene Secures $5.8 Million R&D Tax Refund to Advance Cancer Therapies
PremiumCompany Announcements
Imugene Secures $5.8 Million R&D Tax Refund to Advance Cancer Therapies
17d ago
Imugene Initiates Phase II Trial for PD1-Vaxx in Colorectal Cancer
PremiumCompany Announcements
Imugene Initiates Phase II Trial for PD1-Vaxx in Colorectal Cancer
24d ago
Imugene’s Resolutions Passed at Extraordinary General Meeting
PremiumCompany Announcements
Imugene’s Resolutions Passed at Extraordinary General Meeting
25d ago
Imugene Advances Cancer Therapy Development with Promising Results
PremiumCompany AnnouncementsImugene Advances Cancer Therapy Development with Promising Results
25d ago
Imugene Secures US Patent for Oncolytic Virotherapy, Strengthening Global IP Position
Premium
Company Announcements
Imugene Secures US Patent for Oncolytic Virotherapy, Strengthening Global IP Position
1M ago
Imugene Limited Announces Cessation of Securities
Premium
Company Announcements
Imugene Limited Announces Cessation of Securities
1M ago
Imugene Launches Phase II Trial for PD1-Vaxx in Colorectal Cancer
PremiumCompany Announcements
Imugene Launches Phase II Trial for PD1-Vaxx in Colorectal Cancer
2M ago
Imugene Appoints Dr. John Byon as Chief Medical Officer to Advance Cancer Immunotherapy
PremiumCompany Announcements
Imugene Appoints Dr. John Byon as Chief Medical Officer to Advance Cancer Immunotherapy
2M ago
Imugene Limited Announces Security Consolidation to Streamline Capital Structure
PremiumCompany Announcements
Imugene Limited Announces Security Consolidation to Streamline Capital Structure
2M ago
Imugene Announces Share Consolidation and Seeks Approval for New Share Issuance
PremiumCompany Announcements
Imugene Announces Share Consolidation and Seeks Approval for New Share Issuance
2M ago
Imugene Issues Addendum to Extraordinary General Meeting Notice
PremiumCompany AnnouncementsImugene Issues Addendum to Extraordinary General Meeting Notice
2M ago
Imugene Limited Announces Extraordinary General Meeting for June 2025
Premium
Company Announcements
Imugene Limited Announces Extraordinary General Meeting for June 2025
2M ago
Imugene Limited Issues New Equity Securities as Part of Employee Incentive Scheme
Premium
Company Announcements
Imugene Limited Issues New Equity Securities as Part of Employee Incentive Scheme
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >